483 related articles for article (PubMed ID: 17522097)
1. Recurrent major infections in juvenile-onset systemic lupus erythematosus--a close link with long-term disease damage.
Lee PP; Lee TL; Ho MH; Wong WH; Lau YL
Rheumatology (Oxford); 2007 Aug; 46(8):1290-6. PubMed ID: 17522097
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
[TBL] [Abstract][Full Text] [Related]
3. Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients.
Yu HH; Wang LC; Lee JH; Lee CC; Yang YH; Chiang BL
Rheumatology (Oxford); 2007 Sep; 46(9):1492-4. PubMed ID: 17673480
[TBL] [Abstract][Full Text] [Related]
4. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
Mikdashi J; Handwerger B
Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927
[TBL] [Abstract][Full Text] [Related]
5. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study.
Ravelli A; Duarte-Salazar C; Buratti S; Reiff A; Bernstein B; Maldonado-Velazquez MR; Beristain-Manterola R; Maeno N; Takei S; Gerloni V; Spencer CH; Pratsidou-Gertsi P; Ruperto N; Pistorio A; Martini A
Arthritis Rheum; 2003 Aug; 49(4):501-7. PubMed ID: 12910556
[TBL] [Abstract][Full Text] [Related]
6. A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus.
Gutiérrez-Suárez R; Ruperto N; Gastaldi R; Pistorio A; Felici E; Burgos-Vargas R; Martini A; Ravelli A
Arthritis Rheum; 2006 Sep; 54(9):2989-96. PubMed ID: 16947634
[TBL] [Abstract][Full Text] [Related]
7. Herpes zoster in juvenile-onset systemic lupus erythematosus: incidence, clinical characteristics and risk factors.
Lee PP; Lee TL; Ho MH; Wong WH; Lau YL
Pediatr Infect Dis J; 2006 Aug; 25(8):728-32. PubMed ID: 16874173
[TBL] [Abstract][Full Text] [Related]
8. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G
J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
[TBL] [Abstract][Full Text] [Related]
9. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
Mok CC; Ho LY; Cheung MY; Yu KL; To CH
Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
[TBL] [Abstract][Full Text] [Related]
10. The rate and pattern of organ damage in late onset systemic lupus erythematosus.
Maddison P; Farewell V; Isenberg D; Aranow C; Bae SC; Barr S; Buyon J; Fortin P; Ginzler E; Gladman D; Hanly J; Manzi S; Nived O; Petri M; Ramsey-Goldman R; Sturfelt G;
J Rheumatol; 2002 May; 29(5):913-7. PubMed ID: 12022349
[TBL] [Abstract][Full Text] [Related]
11. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.
Zonana-Nacach A; Yañez P; Jiménez-Balderas FJ; Camargo-Coronel A
Lupus; 2007; 16(12):997-1000. PubMed ID: 18042596
[TBL] [Abstract][Full Text] [Related]
12. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
Brunner HI; Gladman DD; Ibañez D; Urowitz MD; Silverman ED
Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232
[TBL] [Abstract][Full Text] [Related]
13. Influence of age at disease onset in the outcome of paediatric systemic lupus erythematosus.
Descloux E; Durieu I; Cochat P; Vital-Durand D; Ninet J; Fabien N; Cimaz R
Rheumatology (Oxford); 2009 Jul; 48(7):779-84. PubMed ID: 19416945
[TBL] [Abstract][Full Text] [Related]
14. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality.
Becker-Merok A; Nossent HC
J Rheumatol; 2006 Aug; 33(8):1570-7. PubMed ID: 16845708
[TBL] [Abstract][Full Text] [Related]
15. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C
Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326
[TBL] [Abstract][Full Text] [Related]
16. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study.
Appenzeller S; Pereira DA; Costallat LT
Lupus; 2008 Nov; 17(11):1023-8. PubMed ID: 18852227
[TBL] [Abstract][Full Text] [Related]
17. Non-tuberculous mycobacterial infection in patients with systemic lupus erythematosus.
Mok MY; Wong SS; Chan TM; Fong DY; Wong WS; Lau CS
Rheumatology (Oxford); 2007 Feb; 46(2):280-4. PubMed ID: 16861709
[TBL] [Abstract][Full Text] [Related]
18. Paediatric systemic lupus erythematosus: prognostic impact of antiphospholipid antibodies.
Descloux E; Durieu I; Cochat P; Vital Durand D; Ninet J; Fabien N; Cimaz R
Rheumatology (Oxford); 2008 Feb; 47(2):183-7. PubMed ID: 18160418
[TBL] [Abstract][Full Text] [Related]
19. [Significance of damage index in predicting systemic lupus erythematosus outcome].
Tarasova IA; Ivanova MM; Zhorniak AP; Nasonova VA
Ter Arkh; 2003; 75(1):59-62. PubMed ID: 12652960
[TBL] [Abstract][Full Text] [Related]
20. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study.
Hiraki LT; Benseler SM; Tyrrell PN; Hebert D; Harvey E; Silverman ED
J Pediatr; 2008 Apr; 152(4):550-6. PubMed ID: 18346514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]